Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagan, H.
Right arrow Articles by Alexander, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagan, H.
Right arrow Articles by Alexander, E. R.
Related Collections
Right arrow Immunization/Vaccines
Right arrow Hepatitis
Right arrow Lesbian/Gay/Bisexual/Transgender Persons
Right arrow Drugs
November 2002, Vol 92, No. 11 | American Journal of Public Health 1756
© 2002 American Public Health Association

RESEARCH AND PRACTICE

Hepatitis B Vaccination Among Research Participants, Seattle, Washington

Holly Hagan, MPH, PhD, Hanne Thiede, DVM, MPH, James P. McGough, PhD, MPH and E. Russell Alexander, MD

The authors are with Public Health—Seattle and King County, Seattle, Wash. Holly Hagan, Hanne Thiede, and E. Russell Alexander are also with the University of Washington School of Public Health and Community Medicine, Seattle.

Correspondence: Requests for reprints should be sent to Holly Hagan, MPH, PhD, Public Health—Seattle and King County, 106 Prefontaine Pl S, Seattle, WA 98104 (e-mail: hagan@ndri.org).

Because this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.


   INTRODUCTION
 
We report here on a protocol to increase hepatitis B virus (HBV) vaccination in participants in 2 research studies in Seattle, Wash. Injection drug users (IDUs) in a cohort study were interviewed and screened for several bloodborne viral infections, including HBV.1 At posttest counseling, participants were informed of their test results, provided risk reduction counseling, and referred to medical services. Prevalence of core antibody to HBV (anti-HBc) was 67%, and only 14% of the participants reported prior HBV vaccination.2 Participants who were anti-HBc negative were given a voucher for a no-cost series of HBV vaccinations redeemable at a public health . . . [Full Text]




This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
J. K. Champion, A. Taylor, S. Hutchinson, S. Cameron, J. McMenamin, A. Mitchell, and D. Goldberg
Incidence of Hepatitis C Virus Infection and Associated Risk Factors among Scottish Prison Inmates: A Cohort Study
Am. J. Epidemiol., March 1, 2004; 159(5): 514 - 519.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Public Health Association